Grants per year
Fingerprint
Dive into the research topics where Ian Anderson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 1 Finished
-
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study.
Li, B. T., Meric-Bernstam, F., Bardia, A., Naito, Y., Siena, S., Aftimos, P., Anderson, I. C., Curigliano, G., de Miguel, M., Kalra, M., Oh, D.-Y., Park, J. O., Postel-Vinay, S., Rha, S. Y., Satoh, T., Spanggaard, I., Michelini, F., Smith, A., Machado, K. K. & Saura, C. & 1 others, , May 3 2024, In: Articles, Abstracts, and Reports.Research output: Contribution to journal › Article
-
Open-label, phase II study of ladiratuzumab vedotin (LV) for castration-resistant prostate cancer (SGNLVA-005, trial-in-progress).
Sher, A. F., Bruce, J. Y., Gabrail, N. Y., Anderson, I. C., Patrikidou, A., Sanborn, R. E., Cho, J. Y., Lee, A. S., Lee, J.-S., Nott, L. M., Oh, D.-Y., Oh, S. C., Oh, S. Y., Wang, Y., Wang, Z. & Guthrie, T. H., Mar 2 2021, In: Articles, Abstracts, and Reports.Research output: Contribution to journal › Article
-
The TIME Trial® Network facilitates rapid clinical trial activation, patient screening, and enrollment in molecularly targeted trials
O'Leary, S., Shulman, M., Ritt, K., Degele, M., Protomastro, E., Clauson, J., Franzen, A., Anderson, I. C., Barve, M. A., Oubre, D. N., Priego, V., Saverimuthu, A., Senecal, F. M., Vaddepally, R. K., Blackwell, K. L. & Cooney, M. M., Jan 1 2021Research output: Other contribution
File4 Downloads (Pure) -
Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials.
Ferrarotto, R., Anderson, I., Medgyasszay, B., García-Campelo, M. R., Edenfield, W., Trevor M, F., Jennifer M, J., Kalmadi, S., Philip E, L., Sanchez-Hernandez, A., Pritchett, Y., Shannon R, M., Rajesh K, M. & Csőszi, T., Sep 1 2021, In: Articles, Abstracts, and Reports.Research output: Contribution to journal › Article
-
Sgnlva-005: Open-label, phase II study of ladiratuzumab vedotin (LV) for advanced aerodigestive tract malignancies.
Anderson, I. C., Wang, Y., Wang, Z. & Sanborn, R. E., Jan 1 2020Research output: Other contribution